Position Statement Developed for Managing Blood Cancers in Pregnancy
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 8, 2025 -- In a new position statement published online Jan. 3 in The Lancet Haematology, guidelines are presented for the management of acute leukemia and aggressive lymphomas in pregnancy.
Georgia Mills, M.B.B.S., from Northern Beaches Hospital in Sydney, and colleagues developed a position statement on the diagnosis and management of acute leukemia and aggressive lymphomas in pregnancy, which pose a unique challenge as both maternal and fetal well-being must be considered.
The authors note that diagnosis of hematological malignancies can be challenging in pregnancy, but timely diagnosis is required, with either a bone marrow aspirate and trephine or lymph node biopsy, or both. Imaging modalities without ionizing radiation are safe in pregnancy, but effects of radiation should be considered. A multidisciplinary collaborative approach to performing imaging in pregnancy is recommended. Furthermore, a multidisciplinary approach to care is required. To avoid conflicting advice to patients, clear, consistent, multidisciplinary communication between teams is imperative. Unless contraindicated, patients should receive standard-of-care hematological management to optimize both relapse-free and overall survival. Consideration of oncological and pregnancy-based issues and their interactions is important. Key clinical considerations include the natural history of the underlying malignancy, parental wishes and expectations, and physiological changes in pregnancy that may impact pharmacokinetics. Access to nursing and midwifery specialists and comprehensive counseling relating to medication exposures during pregnancy and breastfeeding are recommended.
"In providing optimal care, close communication, shared decision-making, and maintaining focus on the goals of a successful pregnancy outcome and a complication-free survival are necessary," the authors write. "Evidence-based and empathic multidisciplinary care is crucial to achieve these aims."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians
MONDAY, July 21, 2025 -- Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study...
Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
MONDAY, July 21, 2025 -- Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus...
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.